Department of Dermatology - Open Access Policy Deposits

eScholarship stats: History by Item for July through October, 2026

Item	Title	Total requests	2026-10	2026-09	2026-08	2026-07
44q8g6b8	Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).	577	50	266	222	39
3455571b	Amitriptyline-induced cutaneous hyperpigmentation: case report and review of psychotropic drug-associated mucocutaneous hyperpigmentation	572	119	152	214	87
0zf2s1cf	Seborrheic Dermatitis: Exploring the Complex Interplay with Malassezia	490	125	132	137	96
6hz8s1mh	Eccrine chromhidrosis secondary to hyperbilirubinemia	489	164	148	126	51
02k9z6qd	Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations	472	162	119	109	82
5c88q182	Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition	413	70	109	197	37
1rd5q5tz	Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis	339	99	48	98	94
5fs883zh	Guidelines of care for the management of atopic dermatitis Section 2. Management and treatment of atopic dermatitis with topical therapies	330	52	129	122	27
1h87c6v1	S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis	317	91	100	88	38
69s5d7c2	Short-Chain Fatty Acids from Cutibacterium acnes Activate Both a Canonical and Epigenetic Inflammatory Response in Human Sebocytes	309	67	96	84	62
8z66m3xd	Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial	302	54	88	126	34
2dn263n7	Skin neurogenic inflammation	281	53	62	119	47
08j6337f	Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris	278	74	85	73	46
5sp112v7	Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus	272	75	68	80	49
62d7n4g9	Designing a broad-spectrum integrative approach for cancer prevention and treatment	270	62	117	66	25
1rw3692c	Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis	269	102	55	84	28
25j8m068	Antimicrobial production by perifollicular dermal preadipocytes is essential to the pathophysiology of acne	261	73	77	84	27
4mj865qb	Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel	249	49	52	112	36
2800q59v	TREM2 macrophages induced by human lipids drive inflammation in acne lesions	245	100	66	40	39
76r5t591	Guidelines of care for the management of atopic dermatitis Section 3. Management and treatment with phototherapy and systemic agents	243	58	40	102	43
4pn6h3g6	The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis	240	70	64	79	27
55q795hc	Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis	240	104	67	45	24
38g465s4	Staphylococcus epidermidis protease EcpA can be a deleterious component of the skin microbiome in atopic dermatitis	234	124	34	41	35
9vr045f7	Guidelines of care for the management of atopic dermatitis Section 4. Prevention of disease flares and use of adjunctive therapies and approaches	231	76	70	66	19
0k43s8nm	Differential Diagnosis of Chronic Spontaneous Urticaria	227	61	64	83	19
8p66q9fv	Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum	224	101	43	41	39
0vp716bx	Pediatric chronic hand eczema: Epidemiology, clinical presentation, and management	222	52	50	74	46
5r79d67k	Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: report of a case and review of the literature	222	76	57	46	43
67t6b870	Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel	219	48	55	69	47
2qr3w771	Urgent safety considerations for dermatologic surgeons in the COVID-19 pandemic	212	56	74	59	23
68c7v95d	Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome	210	60	42	75	33
3m85j4j2	DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth	209	46	58	52	53
7gn5j3gp	Incomplete human reference genomes can drive false sex biases and expose patient-identifying information in metagenomic data	209	43	62	80	24
0g0537ph	Beneficial Effects of Early Pulsed Dye Laser Therapy in Individuals with Infantile Hemangiomas	205	30	24	135	16
5kk7h8hg	Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study	204	43	30	88	43
49f6450d	Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris	203	47	54	64	38
2z6036qj	Guidelines of care for the management of atopic dermatitis Section 1. Diagnosis and assessment of atopic dermatitis	199	57	41	79	22
2bv4q0k3	Obesity alters pathology and treatment response in inflammatory disease	195	57	68	44	26
8sq2t665	Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).	194	27	71	75	21
9dv5d6nh	Novel tretinoin 0.05% lotion for the once‐daily treatment of moderate‐to‐severe acne vulgaris in a preadolescent population	192	50	84	24	34
2qq240fn	Sphingosine 1-Phosphate Signaling at the Skin Barrier Interface	190	58	50	64	18
2vz565gs	Competition between skin antimicrobial peptides and commensal bacteria in type 2 inflammation enables survival of S. aureus	189	64	41	44	40
216788xg	Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study	188	66	52	53	17
05j80943	Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies	183	43	55	56	29
47q8p2w7	Nevoid melanoma and eruptive nevi from erlotinib	181	78	36	34	33
27v10695	Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes	178	37	74	50	17
2xn7z5c4	Botulinum toxin blocks mast cells and prevents rosacea like inflammation	177	53	54	48	22
5xs3g48j	Acne and Rosacea	174	51	37	51	35
0sg0z14s	Genitogluteal porokeratosis in an HIV-positive man: a case report and review of the literature on genital porokeratosis	171	64	40	39	28
3pb085n6	Association of Psychiatric Comorbidities With Chronic Urticaria: A Nested Case‐Control Study in the All of Us Research Program	167	41	49	54	23

Top

Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.